Detalhe da pesquisa
1.
Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI.
Cardiovasc Drugs Ther
; 37(5): 941-953, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35567726
2.
Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trial.
EuroIntervention
; 17(6): 474-480, 2021 Aug 27.
Artigo
Inglês
| MEDLINE | ID: mdl-33164896